New 52-week high$272.42+0.4% vs prior high · 2026-10-07
AbbVie set a fresh 52-week high at $272.42, the second straight day of records for the drugmaker. Keep an eye on whether it holds.
Latest Activity
New 52-week high$266.28+0.1% vs prior high · 2026-08-19
AbbVie cleared its August record with a fresh 52-week high at $266.28, 0.12% above the prior peak, on the same day it announced FDA approval of JUVMO. A $470.9 billion pharma making new highs is a momentum signal income investors rarely get.
- ABBVAbbVie Inc. Common Stock (ABBV)Sell$15K – $50KSep 14
- GOOGLET IRA Alphabet Inc. - Class A Common Stock (GOOGL)Sell$15K – $50KSep 14
Made public 4 days after the earliest trade
Sessions dumped a big pharma name and Alphabet on the same day, then filed within four days, an unusually fast turnaround that pins down the timing. Paired healthcare and megacap tech selling from a sitting House member is a signal to catch before the next leg of either trade.
6stocks hit new 52-week highs this week
- SSentinelOne$20.94+6.1%
- KOCoca-Cola$91.1+2.3%
- EXPEExpedia$321.63+1.3%
- ABNBAirbnb$187.3+1.2%
- ABBVAbbVie$264.96+1.0%
- PFEPfizer$28.07+0.6%
Six names hit fresh 52-week highs this week: SentinelOne led at 6.14% above its prior peak, with Coca-Cola, Expedia, Airbnb, AbbVie and Pfizer all clearing old ceilings too.
New 52-week high$265.97+1.0% vs prior high · 2026-07-29
AbbVie touched a new 52-week high at $265.97, clearing its July 29 peak. The $470 billion pharma has left its spring range near $200 behind.
ABBV Coverage
10:15am ET
Investing
5 Dividend Stocks With Fortress-Like Coverage and Room for Things to Go Wrong
A fat dividend yield means nothing if the cash runs dry before the check clears. These five companies show wildly different margins of safety, and one of them barely cleared the bar…
9:30am ET
Investing
Johnson & Johnson Has Dividend Royalty Status. Does That Make It a Buy?
Johnson & Johnson just logged its 64th straight year of dividend growth, but biosimilar threats, a MedTech slowdown, and lingering talc litigation raise a real question about whether that streak justifies buying…
2:43pm ET
Personal Finance
Forget Bonds: How Retirees Collect $6,650 a Month From Dividends Alone
Treasuries now offer a yield that dividend investors once bragged about, which raises a question most retirees avoid asking: does an equity income portfolio actually come out ahead after risk, taxes, and…
1:00pm ET
Investing
Prediction: LLY Has Another Massive Growth Opportunity Beyond Weight Loss
The 24/7 Wall St. price target for Eli Lilly (NYSE:LLY | LLY Price Prediction) is $1,359.12 over the next 12 months. With the stock at $1,142.85, that implies 18.92% upside. Lilly wins…
8:49am ET
Investing
$100,000 in 5 Dividend Kings Will Generate Close to $4,000 Each Year Safely
When paychecks stop, the wrong income strategy forces you to sell shares at the worst possible moment. Five companies have raised their dividends through every recession and rate shock in modern memory,…
8:25am ET
Investing
AbbVie Rewarded Patient Investors but Punished Those Who Bought on Good News
AbbVie investors who bought on headline-grabbing drug approvals consistently trailed those who bought during fear and uncertainty. The calendar of milestones reveals a counterintuitive pattern about when good news becomes a trap.
3:00pm ET
Investing
This 3-Stock Roth Portfolio Pays $25,849 a Year Without a Federal Tax Bill
Three blue-chip dividend stocks sitting in a taxable account hand a portion of every payout straight to the IRS, but the account type holding them changes that math completely. Here is what…
12:45pm ET
Investing
5 High-Yield Dividend Stocks to Buy for October Income with Cash Flow to Spare
From a pharma giant rebuilding after a blockbuster patent loss to a pipeline partnership targeting double-digit distribution raises through 2027, these five stocks span wildly different industries yet share one thing: cash…
3:39pm ET
Personal Finance
How Much Does a 58-Year-Old Need Invested to Replace a $160,000 Salary With Dividends?
Replacing a $160,000 salary with dividends at 58 sounds like a single math problem, but the required portfolio swings by millions depending on which yield tier you choose, and the tier that…
9:00am ET
Investing
Prediction: Eli Lilly Could Be the Next $2 Trillion Drugmaker
Eli Lilly just posted a 47.7% revenue surge while rivals like Novo Nordisk are watching earnings fall, and a fresh pipeline catalyst could push Lilly toward a valuation Wall Street has only…
9:19am ET
Investing
5 Solid Dividend Stocks to Buy Now
An income portfolio built inside one sector carries one set of risks. This basket spreads five dividend payers across four sectors: consumer staples with Coca-Cola (NYSE:KO | KO Price Prediction) and PepsiCo…
7:15am ET
Investing
5 High-Yield Dividend Stocks That Pass the Coverage Test (Not Just the Yield Test)
With the 10-year Treasury now paying more than most income stocks, five dividend names face a simple question: does real cash actually back the payout, or just the yield number on the…
7:15am ET
Investing
BofA Boosts AbbVie and J&J Price Targets on Growth and Pipeline Strength
Bank of America just raised price targets on two pharma giants facing patent cliffs, but its conviction level differs sharply between them, and the valuation gap may explain which one belongs in…
2:00pm ET
Investing
Johnson & Johnson’s Next Growth Engine Is Taking Shape
Johnson & Johnson's oncology and immunology pipeline is firing on multiple cylinders, but a collapsing blockbuster drug and mounting litigation costs threaten to cancel out every gain. Here is whether the bull…
12:15pm ET
Personal Finance
How to Build $7,250 a Month in Dividend Income Without Owning a Single Yield Trap
Chasing the highest dividend yield is exactly how investors end up owning something that quietly eats their principal alive. A six-holding portfolio shows how a much lower yield can generate far more…